Insulet (PODD) Financial Analysis & Valuation | Quarter Chart
Insulet (PODD)
PODDPrice: $156.89
Fair Value: 🔒
🔒score
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the hand... more
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insul... more
Description
Shares
| Market Cap | $10.87B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Ashley A. McEvoy |
| IPO Date | 2007-05-15 | CAGR | — |
| Employees | 5,400 | Website | www.insulet.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 504793.9% | Total Yield | 504793.9% |
PODD chart loading...
Fundamentals
Technicals
| Enterprise Value | $8.97B | P/E Ratio | 36.66 |
| Forward P/E | 19.22 | PEG Ratio | 0.23 |
| P/S Ratio | — | P/B Ratio | — |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $4.28 | EPS Growth 1Y | -41.33% |
| EPS Growth 3Y | 1307.59% | EPS Growth 5Y | 690.2% |
| Revenue Growth 1Y | 27.12% | Gross Margin | 0.71% |
| Operating Margin | 0.17% | Profit Margin | 0.1% |
| ROE | 0.18% | ROA | 0.08% |
| ROCE | 0.18% | Current Ratio | 2.87 |
| Quick Ratio | 2.18 | Cash Ratio | 1.17 |
| Debt/Equity | 0.06 | Interest Coverage | 14.32 |
| Altman Z Score | 5.58 | Piotroski Score | 7 |